ZBIO
Zenas BioPharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.50
−1.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 39.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.31x
- Price / sales
- 2053.07x
- Price / cash flow
- -9.09x
Enterprise value
- Enterprise value
- $1.8B
- EV / sales
- 1799.54x
- EV / EBITDA
- -3.94x
- EV / EBIT
- -3.78x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026